Pharmaceutical composition for preventing or treating AIDS comprising rhodanine derivative
US10821101B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2019 |
| Grant date | Nov 3, 2020 |
| Priority date | — |
| Expiry date | Aug 29, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7076
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating AIDS, comprising a rhodanine derivative and a nucleoside reverse transcriptase inhibitor. A complex composition of the present invention exhibits a synergistic effect in terms of anti-HIV activity as compared with a case where each of the compounds is used as a single drug. Thus, the composition provides sufficient anti-HIV activity and exhibits an excellent effect of decreasing side effects such as toxicity even in a case where each compound is administered in a small amount. Accordingly, the present invention is expected to greatly contribute to treatment of AIDS patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.